|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
US
|
NASDAQ
|
|
BOLT
|
Bolt Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
CKPT
|
Checkpoint Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CMPX
|
Compass Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
LIXT
|
Lixte Biotechnology Holdings, Inc.
|
US
|
NASDAQ
|
|
XLO
|
Xilio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TIKRF
|
Tikcro Technologies
|
US
|
OTC
|
|
9966
|
Alphamab Oncology
|
HK
|
HK
|
|
IPH
|
Innate Pharma
|
FR
|
PA
|
|
3176
|
Medigen Biotechnology
|
TW
|
TWO
|
|
2US
|
NextCure Inc
|
DE
|
F
|
|
3NK
|
ALPHAMAB ONCOLO.DL-000002
|
DE
|
F
|
|
IDD
|
Innate Pharma S.A
|
DE
|
F
|
|
IDDA
|
INNATE PHARMA SP.ADR/1
|
DE
|
F
|
|
M55
|
MacroGenics Inc
|
DE
|
F
|